pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda press·Jun 11·1 min read
save

FDA grants emergency use authorization for generic Nitenpyram tablets to treat New World screwworm in dogs and cats

Jun 11, 2026·read at fda press ↗RegulatoryPositive

The U.S. Food and Drug Administration has issued an Emergency Use Authorization for generic Nitenpyram tablets to treat New World screwworm infestations in dogs, puppies, cats and kittens that weigh at least two pounds and are at least four weeks old.

This is the first generic animal drug authorized for use against the pest, following an emergency declaration made in August 2025 as part of a broader effort to halt the spread of the infestation.

The FDA said the totality of scientific evidence supports the drug's effectiveness and that the benefits outweigh any known risks. The agency noted it has already issued ten EUAs and three conditional approvals for related countermeasures under the current administration.

source

This writeup was produced by pharmadog from original reporting by fda press.

Original headline: “FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats”

read at fda press ↗
729 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Infectious DiseaseVaccines

related stories

  • Jun 6Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous actionSTAT
  • Jun 5CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasuresSTAT
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • Jun 1STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in fundingSTAT
  • Jun 1Opinion: What should hospitals do when patients demand unvaccinated donor blood?STAT